Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 29 min ago
PreprintAll rights reservedbioRxiv

Engineered probiotics target granulomas to treat mycobacterial infection

1 more authors

Related

  1. Mesaconic acid delivery via biomaterials and engineered probiotics to the gut reduces inflammation in Crohn's Diseases mouse models
    H. Qian, D. Singh, Z. Chen +15
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv
  2. Complementary strategies to target residual immune activation and mucosal dysfunction in treated HIV: role of probiotics and pidotimod
    Katia Falasca, Raffaele Ferri, Jacopo Vecchiet
    Frontiers in Cellular and Infection MicrobiologyPeer-reviewedCC BY 4.0Full textMicrobiologyPMC
  3. Multiscale modeling of host-pathogen interactions and mucociliary clearance during non-tuberculous mycobacterial pulmonary infection
    Jindong Wang, Kali Konstantinopoulos, Po-Chun Kuo +4
    arXivPreprintCC BY 4.0Full textBioinformatics & computational biologyarXiv
  4. L-Serine and Palmitoyl CoA control Mycobacterial infection by tweaking protective immune response: A potential host directed therapy for tuberculosis
    N. Sharma, R. Sharma, A. Kumar +5
    bioRxivPreprintCC BYFull textMicrobiologybioRxiv
  5. Single-cell analysis of West Nile virus infection in brain organoids identified a serine synthesis enzyme as a determinant of viral neural tropism and a druggable antiviral target
    M. Leitner, L. De Hayr, Z. Zhao +11
    bioRxivPreprintAll rights reservedFull textMicrobiologybioRxiv
BibTeX
@misc{chen2026engineered,
  title = {{Engineered probiotics target granulomas to treat mycobacterial infection}},
  author = {Yu-Yu Chen and Tetsuhiro Harimoto and Gaëlle Guiewi Makafe and Courtney Coker and Hannah Kim and Jongwon Im and Yuanqi Jing and Hayoung Jin and Xiaoyu Hu and Sharicka Zutshi and Mia Ross Raneri and Brian Weinrick and Tal Danino},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.27.762313},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.27.762313v1},
}
RIS
TY  - UNPB
TI  - Engineered probiotics target granulomas to treat mycobacterial infection
AU  - Yu-Yu Chen
AU  - Tetsuhiro Harimoto
AU  - Gaëlle Guiewi Makafe
AU  - Courtney Coker
AU  - Hannah Kim
AU  - Jongwon Im
AU  - Yuanqi Jing
AU  - Hayoung Jin
AU  - Xiaoyu Hu
AU  - Sharicka Zutshi
AU  - Mia Ross Raneri
AU  - Brian Weinrick
AU  - Tal Danino
PY  - 2026
DA  - 2026/10/27
PB  - bioRxiv
DO  - 10.64898/2026.10.27.762313
UR  - https://www.biorxiv.org/content/10.64898/2026.10.27.762313v1
SN  - 2692-8205
ER  -